TRIM7 acts as an antiviral factor during SARS-CoV-2 infection, by ubiquitinating the M protein on K14 and inhibiting caspase-6-dependent apoptosis. The natural K14 mutations in circulating strains support the physiological role of M ubiquitination.
- Maria Gonzalez-Orozco
- Hsiang-chi Tseng
- Ricardo Rajsbaum